Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zanidatamab in HER2-positive Advanced Solid Tumors
NCT07631871Phase 2Not yet recruiting
- Sponsor
- Haihua Yuan
- Start
- Jun 2026
- Primary completion
- Dec 2029
01
Overview
A Phase 2 trial of zanidatamab in solid tumor, sponsored by Haihua Yuan. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
zanidatamab
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07631871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07631871.